FDA Reclassifies Image Analyzers from Class III to Class II Devices
Today FDA announced that it is reclassifying certain medical image analyzers from Class III to Class II devices. These devices include specific radiological medical image analyzers such as computer-assisted detection (CADe) devices for mammography breast cancer, ultrasound breast lesions, radiograph lung nodules, and radiograph dental caries detection devices. These devices will be subject to 510(k) premarket notification. The agency’s final order has special controls (in addition to the general controls) to provide reasonable assurance of device safety and effectiveness. The move also streamlines the review process for CADes to allow patients faster access to these devices.
The final order will be published on the Federal Register on Wednesday, January 22.
The FDA also released the guidance document, Clinical Performance Assessment: Considerations for Computer-Assisted Detection Devices Applied to Radiology Images and Radiology Device Data – Premarket Approval (PMA) and Premarket Notification [510(k)] Submissions.
Related Articles
-
The draft guidance proposes updates to clarify how the Breakthrough Devices Program may be applicable to certain medical devices that promote health equity, as well as considerations in designating eligible devices that may benefit populations impacted by disparities in health…
-
With the ever-increasing adoption of connected devices, the agency is emphasizing the need for effective cybersecurity.
-
The FDA is hosting a webinar on February 2 for interested stakeholders to discuss the final guidance Electromagnetic Compatibility (EMC) of Medical Devices and its applicability to in vitro diagnostic (IVD) devices.
-
Effective February 7, the agency will conduct inspections across all commodities, as well as mission-critical foreign and domestic inspections.
